{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-04-01",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Ongoing",
      "city": "Morrisville",
      "state": "NC",
      "country": "United States",
      "classification": "Class II",
      "openfda": {},
      "product_type": "Devices",
      "event_id": "88206",
      "recalling_firm": "Cellex",
      "address_1": "507 Airport Blvd Ste 107",
      "address_2": "N/A",
      "postal_code": "27560-8200",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Telephone",
      "distribution_pattern": "US Nationwide distribution in the states of CA, FL, TX, and WI.",
      "recall_number": "Z-2452-2021",
      "product_description": "Cellex qSARS-Cov-2 Antigen Rapid Test, 25 tests/box, submitted as EUA202955 \"declined to issue\"",
      "product_quantity": "Approximately 44,821 kits",
      "reason_for_recall": "The kit does not have an emergency use authorization (EUA).",
      "recall_initiation_date": "20210301",
      "center_classification_date": "20210913",
      "report_date": "20210922",
      "code_info": "All lot numbers",
      "more_code_info": ""
    }
  ]
}